Institute-Associated Research Group "Cell adhesion and cell polarity", University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
Institute of Medical Biochemistry, ZMBE, University of Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany.
BMC Mol Cell Biol. 2020 Apr 17;21(1):30. doi: 10.1186/s12860-020-00274-1.
Transmembrane and immunoglobulin domain-containing protein 1 (TMIGD1) is a recently identified cell adhesion molecule which is predominantly expressed by epithelial cells of the intestine and the kidney. Its expression is downregulated in both colon and renal cancer suggesting a tumor suppressive activity. The function of TMIGD1 at the cellular level is largely unclear. Published work suggests a protective role of TMIGD1 during oxidative stress in kidney epithelial cells, but the underlying molecular mechanisms are unknown.
In this study, we address the subcellular localization of TMIGD1 in renal epithelial cells and identify a cytoplasmic scaffold protein as interaction partner of TMIGD1. We find that TMIGD1 localizes to different compartments in renal epithelial cells and that this localization is regulated by cell confluency. Whereas it localizes to mitochondria in subconfluent cells it is localized at cell-cell contacts in confluent cells. We find that cell-cell contact localization is regulated by N-glycosylation and that both the extracellular and the cytoplasmic domain contribute to this localization. We identify Synaptojanin 2-binding protein (SYNJ2BP), a PDZ domain-containing cytoplasmic protein, which localizes to both mitochondria and the plasma membrane, as interaction partner of TMIGD1. The interaction of TMIGD1 and SYNJ2BP is mediated by the PDZ domain of SYNJ2BP and the C-terminal PDZ domain-binding motif of TMIGD1. We also find that SYNJ2BP can actively recruit TMIGD1 to mitochondria providing a potential mechanism for the localization of TMIGD1 at mitochondria.
This study describes TMIGD1 as an adhesion receptor that can localize to both mitochondria and cell-cell junctions in renal epithelial cells. It identifies SYNJ2BP as an interaction partner of TMIGD1 providing a potential mechanism underlying the localization of TMIGD1 at mitochondria. The study thus lays the basis for a better understanding of the molecular function of TMIGD1 during oxidative stress regulation.
跨膜和免疫球蛋白结构域蛋白 1(TMIGD1)是一种新发现的细胞黏附分子,主要在肠道和肾脏的上皮细胞中表达。其在结肠癌和肾癌中的表达均下调,提示其具有肿瘤抑制活性。TMIGD1 在细胞水平上的功能尚不清楚。已发表的研究工作表明,TMIGD1 在肾上皮细胞的氧化应激中具有保护作用,但潜在的分子机制尚不清楚。
在本研究中,我们研究了 TMIGD1 在肾上皮细胞中的亚细胞定位,并鉴定了一种细胞质支架蛋白作为 TMIGD1 的相互作用伙伴。我们发现,TMIGD1 在肾上皮细胞中定位于不同的隔室,且这种定位受细胞密度的调节。在亚汇合细胞中,TMIGD1 定位于线粒体,而在汇合细胞中则定位于细胞-细胞连接处。我们发现,细胞-细胞接触定位受 N-糖基化调节,且胞外和胞质结构域均有助于这种定位。我们鉴定了突触结合蛋白 2 结合蛋白(SYNJ2BP),一种含有 PDZ 结构域的细胞质蛋白,它既定位在线粒体上,也定位在质膜上,是 TMIGD1 的相互作用伙伴。TMIGD1 和 SYNJ2BP 的相互作用由 SYNJ2BP 的 PDZ 结构域和 TMIGD1 的 C 端 PDZ 结构域结合基序介导。我们还发现,SYNJ2BP 可以将 TMIGD1 主动募集到线粒体,为 TMIGD1 定位于线粒体提供了一种潜在的机制。
本研究将 TMIGD1 描述为一种黏附受体,可在肾上皮细胞中定位于线粒体和细胞-细胞连接处。它鉴定了 SYNJ2BP 是 TMIGD1 的相互作用伙伴,为 TMIGD1 定位于线粒体提供了潜在的机制。因此,本研究为更好地理解 TMIGD1 在氧化应激调节中的分子功能奠定了基础。